Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

University of Toronto

$70,000.00

Molecular Mechanisms of Bone Programming by Early Exposure to Soy Isoflavones

FY 2009-10

Summary
By the year 2020, one in two individuals over the age of 50 will be at risk of fracture from osteoporosis in developed countries. Fragility fractures are associated with high rates of morbidity and mortality. Thus, there is an urgent need to develop interventions to combat osteoporosis. Since there is no ideal treatment for osteoporosis, establishing novel prevention strategies may reduce the risk of fragility fractures during aging. A recent study from our lab showed that exposure to soy isoflavones (a dietary estrogen) for the first 5 days of life results in healthier (i.e. stronger) bones at adulthood in mice. Improvements in bone mass and strength at adulthood protects against deterioration of bone tissue during aging. Importantly, the isoflavone levels tested in our mouse model are equivalent to the levels that human infants consume from soy protein formula. Thus, early exposure to soy isoflavones at levels attainable through diet alone may provide a novel strategy that maximizes bone health during development and prevents osteoporosis in later life. The proposed studies involve treating newborn mice with soy isoflavones for the first 10 days of life (representing the first year of life in infants) to determine how improvements in bone health (i.e. greater bone mineral density, improved bone structure and high bone strength) are exhibited at young adulthood. Estrogen receptors and bone specific genes critical to bone health will be measured to determine if and how they mediate the positive effects of early exposure to soy isoflavones on later bone health. To determine if benefits to bone health are transferred to the next generation, bone mineral density, bone structure and bone strength will be measured in the offspring at young adulthood. Positive findings may help in developing nutritional guidelines to maximize bone health and in formulating a safe, preventive strategy to reduce the risk of osteoporosis during aging.
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
206148
Name
Kaludjerovic Jovana
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Molecular Mechanisms of Bone Programming by Early Exposure to Soy Isoflavones
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$70,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Biomechanical Bone Strength; Bone Metabolism; Bone Microarchitecture; Bone Programming; Early Development; Epigenetics; Gene Transcription; Small Animal Research; Soy Isoflavones
Abstract
By the year 2020, one in two individuals over the age of 50 will be at risk of fracture from osteoporosis in developed countries. Fragility fractures are associated with high rates of morbidity and mortality. Thus, there is an urgent need to develop interventions to combat osteoporosis. Since there is no ideal treatment for osteoporosis, establishing novel prevention strategies may reduce the risk of fragility fractures during aging. A recent study from our lab showed that exposure to soy isoflavones (a dietary estrogen) for the first 5 days of life results in healthier (i.e. stronger) bones at adulthood in mice. Improvements in bone mass and strength at adulthood protects against deterioration of bone tissue during aging. Importantly, the isoflavone levels tested in our mouse model are equivalent to the levels that human infants consume from soy protein formula. Thus, early exposure to soy isoflavones at levels attainable through diet alone may provide a novel strategy that maximizes bone health during development and prevents osteoporosis in later life. The proposed studies involve treating newborn mice with soy isoflavones for the first 10 days of life (representing the first year of life in infants) to determine how improvements in bone health (i.e. greater bone mineral density, improved bone structure and high bone strength) are exhibited at young adulthood. Estrogen receptors and bone specific genes critical to bone health will be measured to determine if and how they mediate the positive effects of early exposure to soy isoflavones on later bone health. To determine if benefits to bone health are transferred to the next generation, bone mineral density, bone structure and bone strength will be measured in the offspring at young adulthood. Positive findings may help in developing nutritional guidelines to maximize bone health and in formulating a safe, preventive strategy to reduce the risk of osteoporosis during aging.
Competitiondate
200910
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Kaludjerovic, Jovana
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $70,000~ $0~